This Month in JAAD Case Reports: June 2023 Spesolimab for Pyoderma Gangrenosum.

Detalles Bibliográficos
Publicado en:Journal of the American Academy of Dermatology Vol. 88; no. 6; pp. 1261 - 1262
Autor principal: Sloan, Brett
Formato: Journal Article
Publicado: Elsevier B.V. Jun2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=164020712&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 164020712
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01909622
        1ZF
      jtl: Journal of the American Academy of Dermatology
      issn: 01909622
      maglogo: N
    pubinfo:
      dt: Jun2023
      vid: 88
      iid: 6
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        164020712
        10.1016/j.jaad.2023.03.007
        164020712
      ppf: 1261
      ppct: 1
      formats:
      tig:
        atl: This Month in JAAD Case Reports: June 2023 Spesolimab for Pyoderma Gangrenosum.
      aug:
        au: Sloan, Brett
        affil: Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N